Interventional Oncology Devices | Market Insights | Latin America (Supplemental) | 2022
Despite the short-term challenges posed by the COVID-19 pandemic, the Latin America interventional oncology device market will see moderate growth through 2031 driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors. However, a lack of reimbursement and pricing pressures will remain a challenge.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Latin America region from 2019 through 2031.
